Table of Contents
ISRN Hematology
Volume 2011 (2011), Article ID 810708, 7 pages
http://dx.doi.org/10.5402/2011/810708
Clinical Study

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary

3rd Department of Internal Medicine, Institute for Internal Medicine, Medical and Health Science Center, University of Debrecen, 4032 Debrecen, Hungary

Received 20 August 2011; Accepted 12 September 2011

Academic Editors: A. Bosly and O. Reman

Copyright © 2011 Zsófia Miltényi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. C. Chang, P. C. H. Chen, D. Jones, and I. J. Su, 鈥淐hanging patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan,鈥 Cancer Science, vol. 99, no. 2, pp. 345鈥349, 2008. View at PublisherView at Google ScholarView at Scopus
  2. O. Landgren and N. E. Caporaso, 鈥淣ew aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma,鈥 Hematology/Oncology Clinics of North America, vol. 21, no. 5, pp. 825鈥840, 2007. View at PublisherView at Google ScholarView at Scopus
  3. G. J. MacFarlane, T. Evstifeeva, P. Boyle, and S. Grufferman, 鈥淚nternational patterns in the occurrence of Hodgkin's disease in children and young adult males,鈥 International Journal of Cancer, vol. 61, no. 2, pp. 165鈥169, 1995. View at PublisherView at Google ScholarView at Scopus
  4. http://www.lymphomainfo.net/.
  5. http://info.cancerresearchuk.org/.
  6. R. J. Lukes, L. F. Craver, and T. C. Hall, 鈥淩eport of the nomenclatura committee,鈥 Cancer Research, vol. 26, p. 1311, 1988. View at Google Scholar
  7. N. L. Harris, E. S. Jaffe, J. Diebold et al., 鈥淭he World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997,鈥 Histopathology, vol. 36, no. 1, pp. 69鈥89, 2000. View at PublisherView at Google ScholarView at Scopus
  8. P. P. Carbone, H. S. Kaplan, and K. Musshoff, 鈥淩eport of the committee on Hodgkin's disease staging classification,鈥 Cancer Research, vol. 31, no. 11, pp. 1860鈥1861, 1971. View at Google ScholarView at Scopus
  9. T. A. Lister, D. Crowther, S. B. Sutcliffe et al., 鈥淩eport of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting,鈥 Journal of Clinical Oncology, vol. 7, no. 11, pp. 1630鈥1636, 1989. View at Google ScholarView at Scopus
  10. M. Tubiana, M. Henry-Amar, P. Carde et al., 鈥淭oward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964鈥1987,鈥 Blood, vol. 73, no. 1, pp. 47鈥56, 1989. View at Google ScholarView at Scopus
  11. D. Hasenclever and V. Diehl, 鈥淎 prognostic score for advanced Hodgkin's disease,鈥 The New England Journal of Medicine, vol. 339, no. 21, pp. 1506鈥1514, 1998. View at PublisherView at Google ScholarView at Scopus
  12. Z. Simon, K. Keresztes, Z. Milt茅nyi et al., 鈥淸Our experiences in treating patients with Hodgkin disease in the last decade],鈥 Orvosi Hetilap, vol. 148, no. 15, pp. 675鈥682, 2007. View at PublisherView at Google Scholar
  13. L. Istv谩n and S. Giczy, 鈥淓pidemiology of Hodgkin's disease,鈥 Orvosi Hetilap, vol. 120, no. 6, pp. 319鈥324, 1979. View at Google ScholarView at Scopus
  14. G. Kel茅nyi and M. V谩rbir贸, 鈥淸Malignant lymphoma reference center-1978],鈥 Orvosi Hetilap, vol. 121, no. 29, pp. 1763鈥1766, 1980. View at Google ScholarView at Scopus
  15. J. L. Iv谩nyi, A. Kiss, B. Telek, K. Pecze, and K. R谩k, 鈥淓xperience with the treatment of Hodgkin's disease (1975-1986),鈥 Orvosi Hetilap, vol. 129, no. 7, pp. 339鈥343, 1988. View at Google ScholarView at Scopus
  16. T. Fleischmann, Malignus Limfom谩s Betegeink N茅h谩ny Retrospekt铆v Adata, Magyar Onkol贸gusok T谩rsas谩ga X. Kongresszusa, Budapest, Hungary, 1985.
  17. E. Ber茅nyi, G. Szegedi, K. Szab贸 et al., 鈥淐omprehensive epidemiologic and clinico-pathologic study of Hodgkin's disease,鈥 Orvosi Hetilap, vol. 130, no. 17, pp. 869鈥874, 1989. View at Google ScholarView at Scopus
  18. J. Endr茅di, T. L谩szl贸, and G. Kel茅nyi, 鈥淟ymphoma referencia centrum 1987鈥88,鈥 Orvosi Hetilap, vol. 132, pp. 733鈥739, 1991. View at Google Scholar
  19. 脕. Ill茅s, G. Vad谩sz, L. Gergely, and G. Szegedi, 鈥淗odgkin-k贸ros betegek kezel茅s茅vel szerzett tapasztalataink,鈥 Magyar Belorvosi Archivum, vol. 51, pp. 283鈥288, 1998. View at Google Scholar
  20. A. Ill茅s, K. Keresztes, Z. Milt茅nyi, and Z. Moln谩r, 鈥淎 Hodgkin-k贸r hazai epidemiol贸giai 茅s kezel茅si adatai,鈥 Hematol贸gia Transzfuziol贸gia, vol. 37, pp. 153鈥163, 2004. View at Google Scholar
  21. R. A. Cartwright and G. Watkins, 鈥淓pidemiology of Hodgkin's disease: a review,鈥 Hematological Oncology, vol. 22, no. 1, pp. 11鈥26, 2004. View at PublisherView at Google ScholarView at Scopus
  22. R. Cartwright, R. McNally, E. Roman, J. Simpson, and J. Thomas, 鈥淚ncidence and time trends in Hodgkin's disease: from parts of the United Kingdom (1984鈥1993),鈥 Leukemia and Lymphoma, vol. 31, no. 3-4, pp. 367鈥377, 1998. View at Google ScholarView at Scopus
  23. R. Cartwright, H. Brincker, P. M. Carli et al., 鈥淭he rise in incidence of lymphomas in Europe 1985鈥1992,鈥 European Journal of Cancer, vol. 35, no. 4, pp. 627鈥633, 1999. View at PublisherView at Google ScholarView at Scopus
  24. B. Glimelius, G. Enblad, M. K盲lkner et al., 鈥淭reatment of Hodgkin's disease: the Swedish National Care Programme experience,鈥 Leukemia and Lymphoma, vol. 21, no. 1-2, pp. 71鈥78, 1996. View at Google Scholar
  25. R. Somers, Treament Strategy in Hodgkin鈥檚 Disease, vol. 196, INSERM/John Libbey Eurotext, 1999.
  26. Z. Moln谩r, 鈥淎 Hodgkin-k贸r kezel茅s茅nek aktu谩lis k茅rd茅sei,鈥 Hematol贸gia Transzfuziol贸gia, vol. 37, pp. 149鈥151, 2004. View at Google Scholar